Rosemary Westwood
Rosemary Westwood is the public and reproductive health reporter for WWNO/WRKF. She was previously a freelance writer specializing in gender and reproductive rights, a radio producer, columnist, magazine writer and podcast host.
-
A new Louisiana law in effect Oct. 1 will re-classify misoprostol as a dangerous controlled substance. It's used in medication abortions, but also for postpartum hemorrhage and other obstetric issues.
-
Louisiana lawmakers have voted to classify two drugs -- mifepristone and misoprostol --commonly used to induce abortions as "dangerous controlled substances."
-
Louisiana could be the first state to regulate mifepristone and misoprostol in the same way as some narcotics and stimulants. Opponents predict harmful delays in miscarriage and other lawful uses.
-
A new bill in Louisiana seeks to reclassify two abortion pills as "controlled dangerous substances." Someone possessing the pills without a prescription could be punished, including jail time.
-
Florida had been a destination for people in the Deep South to get abortions, but on May first a six-week abortion ban goes into effect there, making the region the most restrictive for the procedure.
-
A troubling new report from Louisiana shows how the state's abortion ban from 2022 is forcing doctors to delay or withhold medical care in ways that make pregnancy more dangerous. -
The Dobbs abortion ruling was centered on the Jackson Women's Health Organization in Mississippi. That clinic was forced to close. But owner Diane Derzis is now opening new clinics in other states.
-
When she was pregnant, Kaitlyn Joshua struggled to get medical care — and answers — in post-Roe Louisiana, where abortion is banned. -
After 42 years, Hope Medical Group for Women will close because Louisiana has banned almost all abortions. The clinic director and some staff may move to a state where abortion is legal.
-
Louisiana's abortion ban makes an exception if the fetus would not survive birth or to save a patient's life. But doctors say they fear that vague wording puts their patients and careers at risk.
